van der Wall SJ, Lip GYH, Teutsch C, Kalejs O, Lyrer P, Hall C, Dubner SJ, Diener HC, Halperin JL, Ma CS, Rothman KJ, Zint K, Zhai D, Huisman MV, GLORIA-AF Investigators. Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study. Eur J Intern Med. 2021 Sep;91:75-80. doi: 10.1016/j.ejim.2021.05.020
Mellor R, Lancaster K, Ritter A. Recovery from alcohol problems in the absence of treatment: a qualitative narrative analysis. Addiction. 2021 Jun;116(6):1413-23. doi: 10.1111/add.15288
Dillon R, Colosia A, Khan S, Masaquel C, McCann E. A systematic literature review of the efficacy and tolerability of polymyxins in resistant Gram-negative infections. Poster presented at the Virtual 2020 30th European Congress of Clinical Microbiology and Infectious Diseases; April 2020. [abstract] ECCMID Abstract Book. 2020 Apr; p.2602.
Garbutt JC, Greenblatt AM, West SL, Morgan LC, Kampov-Polevoy A, Jordan HS, Bobashev GV. Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence. Addiction. 2014 Aug;109(8):1274-84. doi: 10.1111/add.12557
West R, Gilsenan A, Coste F, Zhou X, Brouard R, Nonnemaker J, Curry SJ, Sullivan SD. The ATTEMPT cohort: a multi-national longitudinal study of predictors, patterns and consequences of smoking cessation; introduction and evaluation of internet recruitment and data collection methods. Addiction. 2006 Sep 1;101(9):1352-61.
Mansfield CA, Pattanayak SK, McDow W, MacDonald R, Halpin P. Shades of green: measuring the value of urban forests in the housing market. J Forest Econ. 2005 Dec;11(3):177-99. doi: 10.1016/j.jfe.2005.08.002